Genetics of SLE in mice

Springer Seminars in Immunopathology

Volumn 28, Issue 2, 2006, Pages 83-96

  Kono, Dwight H ^a   Theofilopoulos, Argyrios N ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Animal models; Genes; Loci; Lupus; Susceptibility

Indexed keywords

ANIMAL MODEL; CONGENIC STRAIN; DISEASE MODEL; DISEASE PREDISPOSITION; GENE IDENTIFICATION; GENE LOCUS; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; QUANTITATIVE TRAIT LOCI;

EID: 34247342168     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00281-006-0030-7     Document Type: Review

References (147)

1. Adachi M, Watanabe-Fukunaga R, Nagata S (1993) Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci USA 90:1756-1760
2. Atencio S, Amano H, Izui S et al (2004) Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells. J Immunol 172:4159-4166
3. Bachmaier K, Krawczyk C, Kozieradzki I et al (2000) Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403:211-216
4. Balomenos D, Martin-Caballero J, Garcia MI et al (2000) The cell cycle inhibitor p21 controls T-cell proliferation and sexlinked lupus development. Nat Med 6:171-176
5. Barrat FJ, Meeker T, Gregorio J et al (2005) Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 202:1131-1139
6. Bazzoni F, Beutler B (1995) Comparative expression of TNF-alpha alleles from normal and autoimmune-prone MHC haplotypes. J Inflam 45:106-114
7. Beck JA, Lloyd S, Hafezparast M et al (2000) Genealogies of mouse inbred strains. Nat Genet 24:23-25
8. Behrens TW, Graham RR, Kyogoku C et al (2005) Progress towards understanding the genetic pathogenesis of systemic lupus erythematosus. Novartis Found Symp 267:145-160
9. Boackle SA, Holers VM, Chen X et al (2001) Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 15:775-785
10. Bolland S, Yim YS, Tus K et al (2002) Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(?/?) mice. J Exp Med 195:1167-1174
11. Booker JK, Reap EA, Cohen PL (1998) Expression and function of Fas on cells damaged by gamma-irradiation in B6 and B6/lpr mice. J Immunol 161:4536-4541
12. Botto M, Dell'Agnola C, Bygrave AE et al (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19:56-59
13. Bouillet P, Metcalf D, Huang DC et al (1999) Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286:1735-1738
14. Boule MW, Broughton C, Mackay F et al (2004) Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin- immunoglobulin G complexes. J Exp Med 199:1631-1640
15. Bygrave AE, Rose KL, Cortes-Hernandez J et al (2004) Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol 2:E243
16. Carballo E, Lai WS, Blackshear PJ (1998) Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281:1001-1005
17. Carroll MC (2000) The role of complement in B cell activation and tolerance. Adv Immunol 74:61-88
18. Chen Z, Koralov SB, Kelsoe G (2000) Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J Exp Med 192:1339-1352
19. Chiang B, Bearer E, Ansari A et al (1990) The BM12 mutation and autoantibodies to dsDNA in NZB.H-2bm12 mice. J Immunol 145:94-101
20. Chu JL, Drappa J, Parnassa A et al (1993) The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J Exp Med 178:723-730
21. Chui D, Sellakumar G, Green R et al (2001) Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. Proc Natl Acad Sci USA 98:1142-1147
22. Cohen PL, Caricchio R, Abraham V et al (2002) Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 196:135-140
23. Cornall RJ, Cyster JG, Hibbs ML et al (1998) Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8:497-508
24. Croker BP, Gilkeson G, Morel L (2003) Genetic interactions between susceptibility loci reveal epistatic pathogenic networks in murine lupus. Genes Immun 4:575-585
25. Dang H, Geiser AG, Letterio JJ et al (1995) SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-knockout mice. J Immunol 155:3205-3212
26. Demetriou M, Granovsky M, Quaggin S et al (2001) Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409:733-739
27. Di Cristofano A, Kotsi P, Peng YF et al (1999) Impaired Fas response and autoimmunity in Pten+/? mice. Science 285: 2122-2125
28. Doyle HA, Gee RJ, Mamula MJ (2003) A failure to repair selfproteins leads to T cell hyperproliferation and autoantibody production. J Immunol 171:2840-2847
29. Drappa J, Kamen LA, Chan E et al (2003) Impaired T cell death and lupus-like autoimmunity in T cell-specific adapter proteindeficient mice. J Exp Med 198:809-821
30. Drappa J, Vaishnaw AK, Sullivan KE et al (1996) Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 335:1643-1649
31. Eisenberg RA, Izui S, McConahey PJ et al (1980) Male determined accelerated autoimmune disease in BXSB mice: transfer by bone marrow and spleen cells. J Immunol 125: 1032-1036
32. Elliott JI, McVey JH, Higgins CF (2005) The P2X7 receptor is a candidate product of murine and human lupus susceptibility loci: a hypothesis and comparison of murine allelic products. Arthritis Res Ther 7:R468-R475
33. Erb KJ, Ruger B, von Brevern M et al (1997) Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. J Exp Med 185:329-340
34. Fisher GH, Rosenberg FJ, Straus SE et al (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946
35. Fujimura T, Hirose S, Jiang Yet al (1998) Dissection of the effects of tumor necrosis factor-alpha and class II gene polymorphisms within the MHC on murine systemic lupus erythematosus (SLE). Int Immunol 10:1467-1472
36. Gillmore JD, Hutchinson WL, Herbert J et al (2004) Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination? Immunology 112:255-264
37. Graham RR, Ortmann WA, Langefeld CD et al (2002) Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 71:543-553
38. Hahne M, Peitsch MC, Irmier M et al (1995) Characterization of the non-functional Fas ligand of gld mice. Int Immunol 7:1381-1386
39. Hanayama R, Tanaka M, Miyasaka K et al (2004) Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304:1147-1150
40. Hao Z, Hampel B, Yagita H et al (2004) T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis. J Exp Med 199:1355-1365
41. Haraldsson MK, dela Paz NG, Kuan JG et al (2005) Autoimmune alterations induced by the New Zealand Black Lbw2 locus in BWF1 mice. J Immunol 174:5065-5073
42. Haywood ME, Rogers NJ, Rose SJ et al (2004) Dissection of BXSB lupus phenotype using mice congenic for chromosome 1 demonstrates that separate intervals direct different aspects of disease. J Immunol 173:4277-4285
43. Haywood ME, Rose SJ, Horswell S et al (2006) Overlapping BXSB congenic intervals, in combination with microarray gene expression, reveal novel lupus candidate genes. Genes Immun 7:250-263
44. Hibbs ML, Tarlinton DM, Armes J et al (1995) Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83:301-311
45. Higuchi T, Aiba Y, Nomura T et al (2002) Cutting edge: ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease. J Immunol 168:9-12
46. Hudgins CC, Steinberg RT, Klinman DM et al (1985) Studies of consomic mice bearing the Y chromosome of the BXSB mouse. J Immunol 134:3849-3854
47. Hurov JB, Stappenbeck TS, Zmasek CM et al (2001) Immune system dysfunction and autoimmune disease in mice lacking Emk (Par-1) protein kinase. Mol Cell Biol 21:3206-3219
48. Iwamoto M, Ibnou-Zekri N, Araki K et al (1996) Prevention of murine lupus by an I-E alpha chain transgene: protective role of I-E alpha chain-derived peptides with a high affinity to I-Ab molecules. Eur J Immunol 26:307-314
49. Izui S, Iwamoto M, Fossati L et al (1995) The Yaa gene model of systemic lupus erythematosus. Immunol Rev 144:137-156
50. Izui S, Higaki M, Morrow D et al (1988) The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZW x C57BL/6)F1 male mice, but not in C57BL/6 male mice. Eur J Immunol 18:911-915
51. Jacob CO, Lee SK, Strassmann G (1996) Mutational analysis of TNF-alpha gene reveals a regulatory role for the 3′-untranslated region in the genetic predisposition to lupus-like autoimmune disease. J Immunol 156:3043-3050
52. Jiang Y, Hirose S, Sanokawa-Akakura R et al (1999) Genetically determined aberrant down-regulation of FcgammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus. Int Immunol 11:1685-1691
53. Jiang Y, Hirose S, Abe M et al (2000) Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics 51:429-435
54. Jiang Y, Ohtsuji M, Abe M et al (2001) Polymorphism and chromosomal mapping of the mouse gene for B-cell activating factor belonging to the tumor necrosis factor family (Baff) and association with the autoimmune phenotype. Immunogenetics 53:810-813
55. Jordan MA, Silveira PA, Shepherd DP et al (2000) Linkage analysis of systemic lupus erythematosus induced in diabetes-prone nonobese diabetic mice by Mycobacterium bovis. J Immunol 165:1673-1684
56. Jorgensen TN, Gubbels MR, Kotzin BL (2004) New insights into disease pathogenesis from mouse lupus genetics. Curr Opin Immunol 16:787-793
57. Khare SD, Sarosi I, Xia XZ et al (2000) Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci USA 97:3370-3375
58. Kikuchi S, Fossati-Jimack L, Moll T et al (2005) Differential role of three major New Zealand Black-derived loci linked with Yaa-induced murine lupus nephritis. J Immunol 174:1111-1117
59. Kono DH, Park MS, Szydlik A et al (2001) Resistance to xenobiotic-induced autoimmunity maps to chromosome 1. J Immunol 167:2396-2403
60. Kono DH, Theofilopoulos AN (2006) Genetics of autoantibody production in mouse models of lupus. In: Pollard KM (ed) Autoantibodies and autoimmunity. Wiley, Weinheim, pp 543-562
61. Kono DH, Theofilopoulos AN (in press) Genetics of murine models of autoimmunity. In: Wallace DJ, Hahn BH (eds) Dubois' systemic lupus erythematosus, 6th edn. Williams & Wilkins, Baltimore
62. Kumar KR, Li L, Yan M et al (2006) Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science 312:1665-1669
63. Lai WS, Carballo E, Strum JR et al (1999) Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol 19:4311-4323
64. Laporte C, Ballester B, Mary C et al (2003) The Sgp3 locus on mouse chromosome 13 regulates nephritogenic gp70 autoantigen expression and predisposes to autoimmunity. J Immunol 171:3872-3877
65. Lau CM, Broughton C, Tabor AS et al (2005) RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 202: 1171-1177
66. Lauwerys BR, Wakeland EK (2005) Genetics of lupus nephritis. Lupus 14:2-12
67. Layer K, Lin G, Nencioni A et al (2003) Autoimmunity as the consequence of a spontaneous mutation in Rasgrp1. Immunity 19:243-255
68. Le LQ, Kabarowski JH, Weng Z et al (2001) Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity 14:561-571
69. Lin L, Gerth AJ, Peng SL (2004) Active inhibition of plasma cell development in resting B cells by microphthalmia-associated transcription factor. J Exp Med 200:115-122
70. Liu L, Tran E, Zhao Y et al (2005) Gadd45 beta and Gadd45 gamma are critical for regulating autoimmunity. J Exp Med 202:1341-1347
71. Lovgren T, Eloranta ML, Kastner B et al (2006) Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjogren's syndrome autoantigen-associated RNA. Arthritis Rheum 54:1917-1927
72. Lu Q, Lemke G (2001) Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293:306-311
73. Lynch DH, Watson ML, Alderson MR et al (1994) The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1:131-136
74. Mackay F, Woodcock SA, Lawton P et al (1999) Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190:1697-1710
75. Majeti R, Xu Z, Parslow TG et al (2000) An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103:1059-1070
76. Mariani SM, Matiba B, Armandola EA et al (1994) The APO-1/ Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur J Immunol 24:3119-3123
77. Mary C, Laporte C, Parzy D et al (2000) Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice. J Immunol 165:2987-2996
78. Matsuzawa A, Moriyama T, Kaneko T (1990) A new allele of the lpr locus, lprcg, that complements the gld gene in induction of lymphadenopathy in the mouse. J Exp Med 171:519-531
79. Mecklenbrauker I, Saijo K, Zheng NYet al (2002) Protein kinase Cdelta controls self-antigen-induced B-cell tolerance. Nature 416:860-865
80. Mehling A, Loser K, Varga G et al (2001) Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J Exp Med 194:615-628
81. Merino R, Shibata T, de Kossodo S et al (1989) Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice. Eur J Immunol 19:2131-2137
82. Merino R, Fossati L, Lacour M et al (1992) H-2-linked control of the Yaa gene-induced acceleration of lupus-like autoimmune disease in BXSB mice. Eur J Immunol 22:295-299
83. Miura-Shimura Y, Nakamura K, Ohtsuji M et al (2002) C1q regulatory region polymorphism down-regulating murine c1q protein levels with linkage to lupus nephritis. J Immunol 169:1334-1339
84. Morel L (2004) Mouse models of human autoimmune diseases: essential tools that require the proper controls. PLoS Biol 2:E241
85. Morel L, Blenman KR, Croker BP et al (2001) The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc Natl Acad Sci USA 98:1787-1792
86. Morel L, Tian XH, Croker BP et al (1999) Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity 11:131-139
87. Mountz JD, Yang P, Wu Q et al (2005) Genetic segregation of spontaneous erosive arthritis and generalized autoimmune disease in the BXD2 recombinant inbred strain of mice. Scand J Immunol 61:128-138
88. Murga M, Fernandez-Capetillo O, Field SJ et al (2001) Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity 15:959-970
89. Murphy ED, Roths JB (1979) AY chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum 22:1188-1194
90. Napirei M, Karsunky H, Zevnik B et al (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25:177-181
91. Nishimura H, Nose M, Hiai H et al (1999) Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11:141-151
92. Nishizumi H, Taniuchi I, Yamanashi Y et al (1995) Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3:549-560
93. Oehm A, Behrmann I, Falk W et al (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 267:10709-10715
94. O'Keefe TL, Williams GT, Davies SL et al (1996) Hyperresponsive B cells in CD22-deficient mice. Science 274:798-801
95. O'Keefe TL, Williams GT, Batista FD et al (1999) Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med 189:1307-1313
96. Pisitkun P, Deane JA, Difilippantonio MJ et al (2006) Autoreactive B Cell responses to RNA-Related Antigens Due to TLR7 gene duplication. Science 312(5780):1669-1672
97. Pollard KM, Hultman P (1997) Effects of mercury on the immune system. Met Ions Biol Syst 34:421-440
98. Pritchard NR, Cutler AJ, Uribe S et al (2000) Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcgammaRII. Curr Biol 10:227-230
99. Qu W, Miyazaki T, Terada M et al (2000) Genetic dissection of vasculitis in MRL/lpr lupus mice: a novel susceptibility locus involving the CD72c allele. Eur J Immunol 30:2027-2037
100. Raman K, Mohan C (2003) Genetic underpinnings of autoimmunity-lessons from studies in arthritis, diabetes, lupus and multiple sclerosis. Curr Opin Immunol 15:651-659
101. Richter G, Qin ZH, Diamantstein T et al (1989) Analysis of restriction fragment length polymorphism in lymphokine genes of normal and autoimmune mice. J Exp Med 170:1439-1443
102. Rieux-Laucat F, Le Deist F, Hivroz C et al (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347-1349
103. Roths JB, Murphy ED, Eicher EM (1984) A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J Exp Med 159:1-20
104. Rozzo SJ, Allard JD, Choubey D et al (2001) Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 15:435-443
105. Sadlack B, Lohler J, Schorle H et al (1995) Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur J Immunol 25:3053-3059
106. Salvador JM, Hollander MC, Nguyen AT et al (2002) Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity 16:499-508
107. Seery JP, Carroll JM, Cattell V et al (1997) Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis. J Exp Med 186:1451-1459
108. Seshasayee D, Valdez P, Yan M et al (2003) Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 18:279-288
109. Sestak AL, Nath SK, Harley JB (2005) Genetics of systemic lupus erythematosus: how far have we come? Rheum Dis Clin North Am 31:223-244
110. Silveira PA, Baxter AG (2001) The NOD mouse as a model of SLE. Autoimmunity 34:53-64
111. Sobel ES, Morel L, Baert R et al (2002) Genetic dissection of systemic lupus erythematosus pathogenesis: evidence for functional expression of Sle3/5 by non-T cells. J Immunol 169:4025-4032
112. Sommers CL, Park CS, Lee J et al (2002) A LAT mutation that inhibits T cell development yet induces lymphoproliferation. Science 296:2040-2043
113. Strasser A, Whittingham S, Vaux DL et al (1991) Enforced bcl-2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 88:8661-8665
114. Subramanian S, Yim YS, Liu K et al (2005) Epistatic suppression of systemic lupus erythematosus: fine mapping of Sles1 to less than 1 mb. J Immunol 175:1062-1072
115. Subramanian S, Tus K, Li QZ et al (2006) A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci USA 103:9970-9975
116. Sun H, Lu B, Li RQ et al (2001) Defective T cell activation and autoimmune disorder in Stra13-deficient mice. Nat Immunol 2:1040-1047
117. Suzuki H, Kundig TM, Furlonger C et al (1995) Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268:1472-1476
118. Takahashi T, Tanaka M, Brannan CI et al (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969-976
119. Taylor GA, Carballo E, Lee DM et al (1996) A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4:445-454
120. Tedder TF, Inaoki M, Sato S (1997) The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6:107-118
121. Theofilopoulos AN, Dixon FJ (1985) Murine models of systemic lupus erythematosus. Adv Immunol 37:269-390
122. Tivol EA, Borriello F, Schweitzer AN et al (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541-547
123. Tivol EA, Boyd SD, McKeon S et al (1997) CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J Immunol 158:5091-5094
124. Tsao BP (2004) Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 16:513-521
125. Vinuesa CG, Goodnow CC (2004) Illuminating autoimmune regulators through controlled variation of the mouse genome sequence. Immunity 20:669-679
126. Vinuesa CG, Cook MC, Angelucci C et al (2005) A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435:452-458
127. Wade CM, Kulbokas EJ 3rd, Kirby AW et al (2002) The mosaic structure of variation in the laboratory mouse genome. Nature 420:574-578
128. Wakeland EK, Liu K, Graham RR et al (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity 15:397-408
129. Walport MJ, Davies KA, Botto M (1998) C1q and systemic lupus erythematosus. Immunobiology 199:265-285
130. Wandstrat AE, Nguyen C, Limaye N et al (2004) Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity 21:769-780
131. Wang J, Lo JC, Foster A et al (2001) The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J Clin Invest 108:1771-1780
132. Wang JH, Avitahl N, Cariappa A et al (1998) Aiolos regulates B cell activation and maturation to effector state. Immunity 9:543-553
133. Watanabe-Fukunaga R, Brannan CI, Copeland NG et al (1992) Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317
134. Waterhouse P, Penninger JM, Timms E et al (1995) Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985-988
135. Waters ST, McDuffie M, Bagavant H et al (2004) Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J Exp Med 199:255-264
136. Wilkinson R, Lyons AB, Roberts D et al (2002) Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) acts as a regulator of B-cell development, B-cell antigen receptor (BCR)-mediated activation, and autoimmune disease. Blood 100:184-193
137. Willerford DM, Chen J, Ferry JA et al (1995) Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521-530
138. Wither JE, Lajoie G, Heinrichs S et al (2003) Functional dissection of lupus susceptibility loci on the New Zealand black mouse chromosome 1: evidence for independent genetic loci affecting T and B cell activation. J Immunol 171:1697-1706
139. Wither JE, Loh C, Lajoie G et al (2005) Colocalization of expansion of the splenic marginal zone population with abnormal B cell activation and autoantibody production in B6 mice with an introgressed New Zealand Black chromosome 13 interval. J Immunol 175:4309-4319
140. Wu J, Zhou T, He J et al (1993) Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 178:461-468
141. Xu Z, Duan B, Croker BP et al (2005) Genetic dissection of the murine lupus susceptibility locus Sle2: contributions to increased peritoneal B-1a cells and lupus nephritis map to different loci. J Immunol 175:936-943
142. Xue D, Shi H, Smith JD et al (2003) A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, a major lupus autoantigen. Proc Natl Acad Sci USA 100:7503-7508
143. Yajima K, Nakamura A, Sugahara A et al (2003) FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease. Eur J Immunol 33:1020-1029
144. Yoh K, Itoh K, Enomoto A et al (2001) Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int 60:1343-1353
145. Zhang L, Eddy A, Teng YT et al (1995) An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes. Mol Cell Biol 15:6961-6970
146. Zhang Y, Schlossman SF, Edwards RA et al (2002) Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice. Proc Natl Acad Sci USA 99:878-883
147. Zhu J, Liu X, Xie C et al (2005) T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J Clin Invest 115:1869-1878